Revenue: The sum of all revenue fields included for a company's operating activities.
Urogen Pharma (URGN) had Revenue of $50.96M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$50.96M |
$-23.57M |
|
$4.14M |
|
$46.82M |
|
$71.22M |
|
$-20.26M |
|
$-8.08M |
|
$-28.35M |
|
$-28.35M |
|
$-23.57M |
|
$-23.57M |
|
$-23.57M |
|
$-23.57M |
|
$-20.26M |
|
$-20.16M |
|
50.18M |
|
50.18M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$237.46M |
|
$0.62M |
|
$16.23M |
|
$253.69M |
|
$50.63M |
|
$189.53M |
|
$327.31M |
|
$377.94M |
|
$-124.25M |
|
$-124.25M |
|
$-124.25M |
|
48.71M |
|
| Cash Flow Statement Financials | |
$-45.32M |
|
$-20.69M |
|
$65.20M |
|
$112.09M |
|
$111.30M |
|
$-0.80M |
|
$4.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.69 |
|
-- |
|
-- |
|
2.90 |
|
-1.53 |
|
91.88% |
|
-39.76% |
|
-39.76% |
|
-- |
|
-55.63% |
|
-46.26% |
|
$-45.37M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
0.20 |
|
0.92 |
|
97.86 |
|
18.97% |
|
18.97% |
|
-9.29% |
|
-36.11% |
|
$-2.55 |
|
$-0.90 |
|
$-0.90 |
|